What's Happening?
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals are set to appear on the RedChip Small Stocks, Big Money show on Bloomberg TV. The program, airing on December 27, will feature interviews with key
executives from both companies. David Young, President of Processa Pharmaceuticals, will discuss the company's Next Generation Cancer platform and provide updates on its Phase 2 study of NGC-Cap for advanced breast cancer. Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, will highlight the company's efforts in combating infectious diseases, focusing on ARAKODA, an FDA-approved antimalarial drug. The show aims to provide insights into the companies' innovative approaches and ongoing clinical trials.
Why It's Important?
The appearance of Processa and 60 Degrees Pharmaceuticals on Bloomberg TV underscores the growing interest in innovative pharmaceutical solutions. Processa's focus on developing safer and more effective cancer treatments could have significant implications for oncology patients, potentially offering improved therapeutic options. Meanwhile, 60 Degrees Pharmaceuticals' work on expanding the use of ARAKODA for other diseases like babesiosis highlights the importance of addressing emerging health threats. The exposure on a major platform like Bloomberg TV can enhance visibility for these companies, potentially attracting investor interest and facilitating further research and development efforts.
